Concepedia

Author

Serena Mancarella

Gastroenterology Hospital "Saverio de Bellis"ORCID

Also Known As

Mancarella, Serena, S. Mancarella, Serena Mancarella

39

Publications

1.5K

Citations

18

H-Index

37

Concepts

All Affiliations

Gastroenterology Hospital "Saverio de Bellis"University of Bari Aldo MoroUniversity of RegensburgInstitut d'Investigació Biomédica de BellvitgeUniversitat de Barcelona
SM

About

Serena Mancarella is an author at Gastroenterology Hospital "Saverio de Bellis" specializing in medicine, liver physiology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

137

2

Cell Biology

4

4

103

3

Health Sciences

3

3

104

4

Hepatology

3

3

64

5

Cellular Physiology

1

1

15

Serena Mancarella

×

14

Publications

619

Citations

14

H-Index

YearCitations

Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination

Amalia Azzariti, Serena Mancarella, Letizia Porcelli,

Hepatology

2016

102

Polymer‐Coated Magnetic Nanoparticles for Curcumin Delivery to Cancer Cells

Serena Mancarella, Valentina Greco, Francesca Baldassarre,

Macromolecular Bioscience

2015

69

Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis

Serena Mancarella, Grazia Serino, Francesco Dituri,

Cell Death and Differentiation

2020

67

CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype

Serena Mancarella, Grazia Serino, Isabella Gigante,

Journal of Experimental & Clinical Cancer Research

2022

60

Epigenetic upregulation and functional role of the mitochondrial aspartate/glutamate carrier isoform 1 in hepatocellular carcinoma

Vittoria Infantino, Francesco Dituri, Paolo Convertini,

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

2018

55

NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC

Yuan Cao, Rahul Agarwal, Francesco Dituri,

Cell Death and Disease

2017

52

Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression

Bhavna Rani, Andrea Malfettone, Francesco Dituri,

Cell Death and Disease

2018

44

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Antonio Cigliano, Shanshan Zhang, Silvia Ribback,

Journal of Experimental & Clinical Cancer Research

2022

40

Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma

Nada Chaoul, Serena Mancarella, L. Lupo,

Cancers

2020

34

Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro

Francesco Dituri, Rosanna Scialpi, Tannin A. Schmidt,

Cell Death and Disease

2020

30

Page 1